End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
113,500 KRW | -1.90% | +2.16% | -9.56% |
06:37am | Green Cross Widens Q1 Loss, Sales Inch Up 2% | MT |
Mar. 20 | GC Biopharma Corp. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Evolution of the average Target Price on GC Biopharma Corp.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
EPS Revisions
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- A006280 Stock
- Consensus GC Biopharma Corp.